TB-500 (Thymosin Beta-4): Comprehensive Research Profile
TB-500 is a synthetic analog of Thymosin Beta-4 (Tβ4), a 43-amino-acid naturally occurring peptide involved in tissue repair and cell migration. As one of the most researched peptides in wound healing and regenerative medicine, TB-500 has attracted substantial attention in preclinical research. This guide covers its molecular characteristics, mechanisms, and research applications.
Molecular Profile
| Parameter | Specification |
|---|---|
| Full Name | Thymosin Beta-4 (Tβ4) |
| Active Fragment | Ac-SDKP (N-terminal fragment) |
| Molecular Formula | C₂₁₂H₃₅₀N₅₆O₇₈S |
| Molecular Weight | 4963.44 g/mol (full Tβ4) |
| CAS Number | 77591-33-4 |
| Appearance | White lyophilized powder |
| Storage | -20°C lyophilized; 2-8°C reconstituted |
Mechanism of Action
Actin Sequestration
The primary mechanism of Tβ4 involves binding to G-actin (globular actin monomers), maintaining a pool of unpolymerized actin available for rapid cytoskeletal reorganization. This is critical for cell migration, which is the first step in wound healing and tissue repair.
Anti-Inflammatory Pathway
Research demonstrates TB-500 reduces inflammatory cytokine expression, modulates NF-κB signaling pathways, decreases inflammatory cell infiltration in damaged tissues, and promotes the transition from inflammatory to proliferative healing phases.
Angiogenesis Promotion
TB-500 has been shown to promote new blood vessel formation through upregulation of VEGF and angiopoietin, endothelial cell migration and tube formation, and enhanced capillary sprouting in ischemic tissue models.
Key Research Areas
Cardiac Research
TB-500 has been extensively studied in cardiac injury models. Research in murine myocardial infarction models has shown improved cardiac function post-injury, reduced scar tissue formation, enhanced cardiomyocyte survival, and promoted cardiac progenitor cell migration.
Dermal Wound Healing
Numerous studies have demonstrated TB-500’s effects on wound healing in animal models, including accelerated wound closure in diabetic mouse models, enhanced keratinocyte and endothelial cell migration, improved collagen deposition and organization, and reduced scarring in full-thickness wound models.
Neurological Research
Emerging research explores TB-500’s neuroprotective and neuroregenerative potential, including oligodendrocyte differentiation and myelination, neuroprotection in traumatic brain injury models, and recovery enhancement in spinal cord injury research.
Laboratory Handling
Reconstitute lyophilized TB-500 with bacteriostatic water. Add solvent slowly along the vial wall to prevent foaming. The reconstituted solution should be clear. Store at 2-8°C and use within 21 days. For long-term storage, aliquot into single-use volumes to avoid freeze-thaw degradation.
Research-Grade TB-500 from Aarise Healthcare
Aarise Healthcare provides high-purity TB-500 (≥98% by HPLC) for qualified research institutions. Each batch includes comprehensive Certificate of Analysis with identity confirmation, purity testing, and sterility documentation. Contact our research compounds division for availability and pricing.
Related Articles
- PEG-MGF (Mechano Growth Factor) Research Guide — Mechanism, Studies & Protocols
- AOD-9604 Peptide Research Guide — Mechanism, Studies & Applications
- DSIP (Delta Sleep-Inducing Peptide) Research Guide — Mechanism, Sleep Studies & Applications
- BPC-157 Peptide Research Guide — Mechanism, Studies & Laboratory Applications
Also from Aarise Group:



